Newleos Therapeutics Receives Up to $15.5M NIH Grant
Newleos Therapeutics, a clinical-stage biotechnology company developing treatments for neuropsychiatric disorders, has received a grant of up to $15.5 million from the National Institute on Drug Abuse (NIDA), part of…